Jamie Christensen - 04 Jan 2024 Form 4 Insider Report for Mirati Therapeutics, Inc.

Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jan 2024
Net transactions value
-$90,038
Form type
4
Filing time
05 Jan 2024, 17:34:07 UTC
Previous filing
03 Jan 2024
Next filing
18 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $90,038 -1,531 -0.96% $58.81 157,135 04 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.